Carlsmed Inc
Research Carlsmed Inc (CARL) on Bullrun: market cap USD 392.60M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCARL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Market capUSD 392.60M
- Financial periodQ2 2026
- RevenueUSD 18.94M
- Net income-USD 10.51M
- Free cash flow-USD 8.11M
- Gross margin76.8%
Valuation Snapshot
latest market cap is USD 392.60M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 50.51M | -USD 29.63M | -USD 29.62M | 75.3% | -2.12 | USD 85.79M | USD 15.35M | USD 98.87M |
| FY2024 | USD 27.17M | -USD 24.26M | -USD 25.65M | 73.8% | -6.11 | USD 40.13M | USD 15.41M | -USD 70.63M |
| FY2023 | USD 13.78M | -USD 18.90M | -USD 17.62M | 71.9% | -0.99 | USD 7.22M | USD 11.39M | -USD 46.13M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 392.60M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 329.30M | n/a | n/a | n/a |
About Carlsmed Inc
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Carlsmed Inc's market cap?
Carlsmed Inc's market capitalization is USD 392.60M.
What does Carlsmed Inc do?
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.